Understanding the Hurdles in Lung Cancer Immunotherapy in the Context of Chronic Obstructive Pulmonary Disease

Am J Respir Crit Care Med. 2018 Oct 1;198(7):835-837. doi: 10.1164/rccm.201803-0523ED.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Humans
  • Immunotherapy
  • Lung Neoplasms*
  • Programmed Cell Death 1 Receptor
  • Pulmonary Disease, Chronic Obstructive*
  • T-Lymphocytes

Substances

  • Programmed Cell Death 1 Receptor